Market Place
Sourcing Support
Somerset`s Generics Lacosamide Receives Approval in US
09 Oct 2024 //
FDA
Chartwell RX Generic Lacosamide Receives Approval in the U.S.
15 May 2024 //
FDA
Medley Pharma`s Generic Lacosamide Receives Approval in the U.S.
02 Apr 2024 //
FDA
Amneal Pharm Generic Lacosamide Receives Approval in the U.S.
27 Mar 2024 //
FDA
Dr. Reddy`s Generic Lacosamide Receives Approval in the U.S.
25 Mar 2024 //
FDA
Aucta debuts generic Vimpat
11 Mar 2024 //
DRUG STORE NEWS
Aucta Pharma Launches First Once-Daily Lacosamide ER Capsule
26 Feb 2024 //
PR NEWSWIRE
Hainan Poly`s Generic Lacosamide Receives Approval in the U.S.
13 Feb 2024 //
FDA
Aurobindo Pharma`s Generic Lacosamide Receives Approval in the U.S.
24 Jan 2024 //
FDA
Congratulations to Shandong on obtaining the CEP certificate for "Lacosamide"
20 Sep 2023 //
PRESS RELEASE
The first domestic imitation of Lacosamide Oral Solution is approved.
20 Sep 2023 //
PRESS RELEASE
Congratulations to Long Nuo Pharma"Lacosamide" for obtaining the CEP certificate
17 Jun 2023 //
PRESS RELEASE
Extrovis` Lacosamide Adroiq (lacosamide) Receives Approval in Europe
05 Jun 2023 //
EMA
Aurobindo`s Generic Lacosamide Receives Approval in the U.S.
05 Jan 2023 //
FDA
Actavis` Generic Lacosamide Receives Approval in the U.S.
05 Jan 2023 //
FDA
Fresenius Targets Treatment of Seizures with Generic Lacosamide Injection
15 Dec 2022 //
BUSINESSWIRE
UCB`s Vimpat Receives Approval in Europe
08 Dec 2022 //
EMA
Apotex`s Generic Lacosamide Receives Approval in the U.S.
23 Sep 2022 //
FDA
Gland`s Generic Lacosamide Receives Approval in the U.S.
19 Sep 2022 //
FDA
Aspiro`s Generic Lacosamide Receives Approval in the U.S.
14 Sep 2022 //
FDA
Novitium`s Generic Lacosamide Receives Approval in the U.S.
26 Aug 2022 //
FDA
Accord healthcare`s Generic Lacosamide Receives Approval in the US
12 Jul 2022 //
FDA
Breckenridge Launches Lacosamide Tablets Manufactured by MSN Laboratories
19 Apr 2022 //
PRNEWSWIRE
The first imitation of lacosamide oral solution in China was approved
18 Apr 2022 //
PRESS RELEASE
FDA approves Indoco Remedies, Lacosamide injection
08 Apr 2022 //
ET HEALTH
Indoco Remedies`s Generic Lacosamide Receives Approval in US
07 Apr 2022 //
FDA
New Launch: Tiefenbacher Pharma Successfully Launches First Generic Version
22 Mar 2022 //
PRESS RELEASE
Indoco`s Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Sciegen Pharms` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Sun Pharma`s Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Glenmark Pharms` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Alembic Pharms` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
MSN Labs` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Amneal Pharm`s Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Hetero Labs` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Indoco`s Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Alkem Labs`s Generic Lacosamide Receives Approval In US
30 Mar 2021 //
FDA
Alkem Labs`s Generic Lacosamide Receives Approval In US
17 Mar 2021 //
FDA
UCB strikes 2 gene therapy deals to build its pipeline
13 Nov 2020 //
BIOPHARMADIVE
Phase 3 data on VIMPAT® (lacosamide) CV in tonic-clonic seizures published
31 Aug 2020 //
BIOSPACE
MSN Labs Generic Lacosamide Receives Tentative Approval In US
14 May 2020 //
FDA
UCB Presents New Data Demonstrating Commitment to Epilepsy
05 Dec 2019 //
PR NEWSWIRE
Letters and drug alerts sent to healthcare professionals in July 2019
19 Aug 2019 //
GOVUK
AZ bags two extensions in latest CHMP decisions
01 Jul 2019 //
PHARMATIMES
Hetero Lab III`s Generic Lacosamide Receives Tentative Approval in US
11 May 2019 //
FDA
Epilepsy Patients Treated With Adjunctive FYCOMPA® (perampanel) CIII
09 May 2019 //
PR NEWSWIRE
Zydus Pharms USA`s Generic Lacosamide Receives Tentative Approval in US
09 Apr 2019 //
FDA
Apotex`s Generic Lacosamide Receives Tentative Approval in US
17 Aug 2018 //
FDA
UCB’s Vimpat gets NHS green light in Wales
08 Mar 2018 //
PHARMA TIMES
Daiichi Sankyo, UCB Japan announce Vimpatò tablets approved for monotherapy
28 Aug 2017 //
PHARMABIZ
Generic Giants Ask Fed. Circ. To Nix Vimpat Patent
09 Aug 2017 //
LAW360
Argentum Persists in Challenging the
23 Mar 2017 //
PR NEWSWIRE
Teva`s Generic Lacosamide Receives Approval In US
01 Mar 2017 //
FDA
Accord`s Generic Lacosamide Receives Tentative Approval In US
06 Feb 2017 //
FDA
Lacosamide has potential as first-line monotherapy for newly diagnosed epilepsy
02 Dec 2016 //
PHARMACEUTICAL JOURNAL
Amneal Pharms Generic Lacosamide Approved In US
09 Sep 2016 //
FDA
Daiichi Sankyo, UCB introduce antiepileptic drug, Vimpat tablets
31 Aug 2016 //
PHARMABIZ
UCB`s Vimpat prevails in patent challenge--but IPR threat still lurks
16 Aug 2016 //
FIERCE PHARMA
